Indivior Pharmaceuticals Inc (INDV) ownership: insiders 1% · institutions 103% · index and ETF funds 9% (13F 2026-03-31). Insider activity, 90 days: Insiders bought (3 sales, 1 open-market buys). SEC EDGAR first-party data.
| Holder | Shares | Market Value | % Outstanding | Reported |
|---|---|---|---|---|
| BlackRock | 18542220.00 | $565.17M | 15.7% | 2026-03-31 |
| Vanguard | 14527426.00 | $442.80M | 12.3% | 2026-03-31 |
| Oaktree Capital Management LP | 6984102.00 | $212.88M | 5.9% | 2026-03-31 |
| State Street | 4903993.00 | $149.47M | 4.2% | 2026-03-31 |
| Two Seas Capital LP | 4746510.00 | $144.67M | 4.0% | 2026-03-31 |
| Millennium Management | 4595535.00 | $140.07M | 3.9% | 2026-03-31 |
| Fuller & Thaler Asset Management, Inc. | 4529583.00 | $138.06M | 3.8% | 2026-03-31 |
| Madison Avenue Partners, LP | 4315162.00 | $131.53M | 3.7% | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Buy | null | 2026-08-05 | |
| Sell | null | 2026-07-10 | |
| Sell | null | 2026-06-22 | |
| Sell | null | 2026-06-22 | |
| Sell | null | 2026-06-22 | |
| Sell | null | 2026-06-11 | |
| Sell | null | 2026-06-08 | |
| Sell | null | 2026-05-13 |
Back to INDV overview · INDV earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.